Breast Cancer Research

official impact factor 5.79

Open Access Highly Access

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes

Golareh Habibi, Samuel Leung, Jennifer H Law, Karen Gelmon, Hamid Masoudi, Dmitry Turbin, Michael Pollak, Torsten O Nielsen, David Huntsman and Sandra E Dunn*

Breast Cancer Research 2008, 10:R86 doi:10.1186/bcr2156

Accesses  

  • Last 30 days: 156 accesses
  • Last year: 1819 accesses
  • All time: 8750 accesses

Cited by

BioMed Central: 4 citations

Review   Free

The Met oncogene and basal-like breast cancer: another culprit to watch out for?

Stefania Gastaldi, Paolo M Comoglio, Livio Trusolino Breast Cancer Research 2010, 12:208 (23 August 2010)

Research article   Open Access Highly Accessed

Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer

Edgar Dahl, Abdelaziz En-Nia, Frank Wiesmann, Renate Krings, Sonja Djudjaj, Elisabeth Breuer, Thomas Fuchs, Peter J Wild, Arndt Hartmann, Sandra E Dunn, Peter R Mertens BMC Cancer 2009, 9:410 (24 November 2009)

Editorial   Free

Approaches towards expression profiling the response to treatment

Andrew H Sims, John MS Bartlett Breast Cancer Research 2008, 10:115 (8 December 2008)

Research article   Open Access

Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells

Anna L Stratford, Christopher J Fry, Curtis Desilets, Alastair H Davies, Yong Y Cho, Yvonne Li, Zigang Dong, Isabelle M Berquin, Philippe P Roux, Sandra E Dunn Breast Cancer Research 2008, 10:R99 (27 November 2008)